The Deal Price Changes Every Time RKLB Moves

Rocket Lab wants to buy Iridium. The deal: $6 billion in equity, $8.1 billion with debt.

Tomorrow, shareholders decide.

But this isn't a simple up-or-down vote. The deal has a moving part. Each Iridium share converts into $27 in cash… plus a variable number of Rocket Lab shares.

Let me explain.

The RKLB shares Iridium holders get depend on Rocket Lab's stock price in the ten days before closing. If RKLB drops, Iridium holders get more shares. If you own RKLB, that means more dilution. If RKLB rises, they get fewer. Less dilution.

Every tick changes the cost.

And last month, SpaceX added a wrinkle. It filed comments with the FCC — not opposing the deal… but raising concerns about spectrum interference between Starlink gateways and Iridium's 19.4–19.6 GHz and 29.1–29.5 GHz bands.

RKLB fell 6% that day.

Because of the variable exchange ratio, regulatory noise doesn't just spook traders. It changes the actual deal math. Price and structure now move together.

So why is Rocket Lab doing this?

Think about SpaceX. It didn't just build rockets. It built Starlink — a constellation that pulls in billions. SpaceX owns the rocket AND the customer.

Rocket Lab wants the same playbook.

Iridium runs 66 active satellites. It has millions of paying subscribers. And it's one of the few space constellations that turns a profit. Buy Iridium, and Rocket Lab stops launching for hire. It launches its own fleet. It sells the data. It controls the whole chain.

Now, you might be thinking: “Rocket Lab is a fraction of SpaceX's size.”

Fair. But Rocket Lab has launched over 50 Electron missions. It's building Neutron. It raised $1.9 billion in a stock sale to fund this deal. It arranged a $3.6 billion credit line — since terminated on Sept. 15. And on Sept. 15, Iridium amended its $1.8 billion term loan to lock in lender consent.

That's not a Hail Mary. That's a plan.

If shareholders approve tomorrow, FCC and DOJ reviews come next. The deal should close around mid-2027.

We'll know more by tomorrow night…

Nvidia?

Palantir?

CrowdStrike?

The next AI stock nobody's heard of yet?

Investors are spending an enormous amount of time trying to guess which AI company will be the biggest winner.

I think there's an easier way to play it.

Instead of betting on one AI stock...

I found a single $38 fund that gives you exposure to dozens of them.

And here's the part that really caught my attention:

It pays income every Thursday.

At its current distribution rate, that could mean as much as $1,051 a month.

From a portfolio built around AI stocks that generally pay little or no dividend themselves.

I put together a short briefing explaining exactly how this works...

Including what the fund owns, where the weekly income comes from, and how investors can potentially collect their first Thursday payment.

Here's the mechanic that makes this deal unusual. Iridium holders get $27 in cash plus Rocket Lab stock — but the number of shares floats inside a collar. If RKLB's 10-day average sits at or below $67.50, they get 0.40 shares; between $67.50 and $112.50 the ratio flexes to keep the stock piece near $27; at $112.50 or above it caps at 0.24 shares. So the deal's real cost to Rocket Lab shareholders isn't fixed — it's a live function of the stock price right up to closing. Watch where RKLB trades in the ten days before the deal closes; that window sets the final dilution.

A rival's paperwork became a price input. SpaceX filed comments with the FCC flagging potential interference between its Starlink gateways and Iridium's spectrum — stopping short of opposing the merger, but putting a regulatory question into the docket. RKLB fell about 6% on the news. Normally a competitor's filing is background noise; here, because the exchange ratio floats with RKLB's price, anything that pushes the stock down quietly raises the share count Iridium holders receive. Regulatory friction and deal cost are now wired together. Watch the FCC docket for how the interference question resolves.

Before the vote, Rocket Lab cleaned up its funding. On Sept. 15 it completed a $1.9 billion at-the-market share sale, and Iridium amended its roughly $1.8 billion term loan so lenders consent to the change of control and the debt can stay in place after closing. With that done, Rocket Lab terminated the $3.6 billion bridge loan it had lined up in June — trading expensive backup debt for a cheaper, permanent structure. The financing is no longer the open question; execution and approvals are. Watch whether the market reads the funded balance sheet as a green light or still frets about the debt load.

Watch tomorrow's tally — but know it's the first gate, not the last.

Here's the sequence. A majority of Iridium shareholders has to approve the merger at the special meeting. Every Iridium director already signed a voting agreement to support it, so approval is likely — but a yes only unlocks the next, slower phase.

After the vote come the regulators. The FCC has to clear the spectrum and license transfers — the same arena where SpaceX just filed its interference concerns — and the DOJ gets its antitrust review. Those processes run on their own clock, which is why the targeted close is all the way out in mid-2027, roughly nine months after a yes vote.

Why the long gap matters to RKLB holders. That stretch is exactly when the exchange ratio is exposed to every twist — each regulatory headline, each move in the stock, feeding back into the final dilution. A deal that's approved isn't a deal that's closed.

So watch two clocks after tomorrow: the FCC docket for how the interference question lands, and RKLB's own price as the closing window approaches. Both write the final terms.

Let's keep this simple.

Picture a trucking company that makes its money hauling other people's freight. It's good at driving, but every dollar depends on someone else needing a delivery. When orders dry up, so does the revenue.

Now imagine that trucking company buys a chain of stores. Suddenly it doesn't just haul freight — it stocks its own shelves, sells its own goods, and hauls them on its own trucks. The driving becomes one link in a chain it owns end to end.

That's what buying Iridium would do for Rocket Lab.

Today Rocket Lab mostly launches other people's satellites. It's a for-hire business: valuable, but dependent on other companies' budgets and schedules. Iridium flips part of that. It brings a constellation that's already in orbit, already serving paying customers, already turning a profit.

So Rocket Lab would stop being only the truck. It would own the cargo, the route, and the customer — building rockets, making satellites, and running a network that sells a service every month.

Here's why that's worth taking on debt and dilution for. A launch-for-hire company gets paid once per flight. A constellation operator gets paid every month, by millions of subscribers, whether or not anyone new books a launch. That recurring revenue is steadier and easier to value — it's the difference between a contractor's paycheck and a landlord's rent.

It's the same reason one company towers over the industry. SpaceX doesn't just launch rockets; it owns Starlink, the customer at the other end of the rocket. Rocket Lab is trying to copy that shape at a fraction of the size — and the Iridium vote is the moment that plan either advances or stalls.

Follow who owns the customer, not just who owns the rocket — that's where the durable money in space is starting to collect.